Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Patent infringement: Roche sues Novartis unit over generic lung disease drug

Ruchika Sharma3 Aug 2023 1:30 PM IST

Swiss drugmaker Roche's Genentech subsidiary has accused a Novartis unit of infringing one of its patents by selling a generic version of its...

Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology

Pfizer sued by GSK for patent infringement over RSV vaccine

Ruchika Sharma3 Aug 2023 12:30 PM IST

A GSK spokesperson said in a statement that intellectual property protections are the "foundation of research-based companies' ability to drive...

Zydus Lifesciences bags USFDA nod for Indomethacin Suppository for rheumatoid arthritis

Ruchika Sharma3 Aug 2023 11:30 AM IST

Indomethacin suppositories is a non-steroidal, anti-inflammatory drug indicated for moderate to severe rheumatoid arthritis including acute flares of...

WHO includes Cadila Pharma Polycap combination in Essential Medicine List

Ruchika Sharma2 Aug 2023 5:48 PM IST

The Polypill formulation (Polycap) is a combination of medications to modify the risk factors like hypercholesterolemia and high blood pressure in...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Pfizer considers cost cuts as demand for COVID products falls

Ruchika Sharma2 Aug 2023 3:30 PM IST

If COVID vaccinations are very low this year, the company will scale back its investments for the virus, including combination shots, as part of its...

Glenmark gets USFDA nod for generic version of AstraZeneca diabetes drug Onglyza

Ruchika Sharma2 Aug 2023 2:30 PM IST

Mumbai: Glenmark Pharmaceuticals Ltd., a research‐led, integrated, global pharmaceutical company has received final approval from the United States...

Daiichi Sankyo Daichirona for Intramuscular Injection approved for manufacturing, marketing as booster vaccination in Japan

Ruchika Sharma2 Aug 2023 1:30 PM IST

DAICHIRONA for Intramuscular Injection is an mRNA vaccine against COVID-19 designed to produce antibodies against the receptor binding domain of the...

India finds lapses at cough syrup maker linked to Cameroon deaths: Govt official

Ruchika Sharma2 Aug 2023 12:30 PM IST

New Delhi: India has found violations related to manufacturing and laboratory practices at drugmaker Riemann Labs, whose cough syrup was linked to...

Lupin arm gets USFDA nod for Fluocinolone Acetonide Topical Oil

Ruchika Sharma2 Aug 2023 11:39 AM IST

Fluocinolone Acetonide Topical Oil will be manufactured at Lupin's Somerset facility in the US.

Lupin secures SBTi validation for emission reduction targets

Lupin Turqoz secures USFDA okay

Ruchika Sharma1 Aug 2023 4:30 PM IST

Mumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food and Drug Administration...

Baxter International issues urgent correction for certain software versions of infusion pumps

Ruchika Sharma1 Aug 2023 3:30 PM IST

The false alarm may lead to an interruption or delay of therapy, and Baxter has received three reports of serious injury potentially associated with...

Aurobindo Pharma arm API facility gets 3 observations from USFDA

Aurobindo Pharma bags USFDA nod for Saxagliptin Tablets

Ruchika Sharma1 Aug 2023 2:45 PM IST

Saxagliptin Tablets, 2.5 mg and 5 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok